PubRank

Gianfranco Parati

Author PubWeight™ 275.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013 12.73
2 European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003 5.94
3 European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013 4.28
4 Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 2002 4.02
5 Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 2009 3.93
6 Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005 3.15
7 Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance. Hypertension 2007 2.93
8 Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007 2.90
9 Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2009 2.71
10 Detecting sodium-sensitivity in hypertensive patients: information from 24-hour ambulatory blood pressure monitoring. Hypertension 2011 2.52
11 European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 2010 2.42
12 Seasonal blood pressure changes: an independent relationship with temperature and daylight hours. Hypertension 2013 2.30
13 ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens 2012 2.24
14 Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation 2012 2.21
15 Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 2012 2.13
16 Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension 2005 2.05
17 Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension 2012 2.02
18 Hypertension and reduced renal function in an 83-year-old patient. Intern Emerg Med 2006 1.92
19 Mechanisms of obesity-induced hypertension. Hypertens Res 2010 1.85
20 Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003 1.74
21 Blood pressure variability and silent cerebral damage in essential hypertension. Am J Hypertens 2004 1.69
22 Ambulatory arterial stiffness index: merits and limitations of a simple surrogate measure of arterial compliance. J Hypertens 2008 1.66
23 Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study. J Hypertens 2011 1.66
24 How to assess mean blood pressure properly at the brachial artery level. J Hypertens 2007 1.61
25 Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study. Circulation 2006 1.54
26 Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial. BMJ 2010 1.53
27 Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study). Am J Physiol Regul Integr Comp Physiol 2003 1.51
28 MagIC System: a New Textile-Based Wearable Device for Biological Signal Monitoring. Applicability in Daily Life and Clinical Setting. Conf Proc IEEE Eng Med Biol Soc 2005 1.50
29 Effects of salt sensitivity on neural cardiovascular regulation in essential hypertension. Hypertension 2005 1.48
30 Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 2012 1.47
31 Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis. J Hypertens 2007 1.42
32 Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure　- Application of Metabolic Exercise Cardiac Kidney Indexes Score. Circ J 2015 1.42
33 Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002 1.42
34 Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens 2013 1.42
35 Carotid artery stenting in patients with acute coronary syndrome: a possible primary therapy for symptomatic carotid stenosis. J Endovasc Ther 2013 1.40
36 Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. Int J Cardiol 2013 1.40
37 Effects of device-guided slow breathing training on exercise capacity, cardiac function and respiratory patterns during sleep in male and female patients with chronic heart failure. Pol Arch Med Wewn 2017 1.39
38 Long-term blood pressure changes induced by the 2009 L'Aquila earthquake: assessment by 24 h ambulatory monitoring. Hypertens Res 2013 1.39
39 Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood 2010 1.37
40 Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects. Hypertension 2005 1.30
41 A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens 2007 1.22
42 Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 2004 1.19
43 Pulmonary hypertension in CKD. Am J Kidney Dis 2012 1.19
44 Impact of telemonitoring at home on the management of elderly patients with congestive heart failure. J Telemed Telecare 2008 1.17
45 Self monitoring of blood pressure at home. BMJ 2004 1.14
46 Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002 1.13
47 Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens 2013 1.12
48 Stress reduction and blood pressure control in hypertension: a role for transcendental meditation? J Hypertens 2004 1.11
49 Scale exponents of blood pressure and heart rate during autonomic blockade as assessed by detrended fluctuation analysis. J Physiol 2010 1.09
50 Self blood pressure monitoring at home by wrist devices: a reliable approach? J Hypertens 2002 1.09
51 Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens 2012 1.09
52 Variables influencing heart rate. Prog Cardiovasc Dis 2009 1.09
53 Prevalence of home blood pressure measurement among selected hypertensive patients: results of a multicenter survey from six hospital outpatient hypertension clinics in Italy. Blood Press 2005 1.09
54 Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006 1.09
55 Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. J Sleep Res 2008 1.08
56 International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol 2013 1.05
57 Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings. J Hypertens 2014 1.04
58 When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Am J Hypertens 2003 1.04
59 Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. J Hypertens 2014 1.03
60 Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007 1.02
61 Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat Rev Nephrol 2012 1.02
62 The role of blood pressure variability in end-organ damage. J Hypertens Suppl 2003 1.02
63 Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation 2009 1.01
64 Diabetic neuropathy is a more important determinant of baroreflex sensitivity than carotid elasticity in type 2 diabetes. Hypertension 2005 1.01
65 Assessing arterial baroreflex control of heart rate: new perspectives. J Hypertens 2004 1.00
66 Ambulatory blood pressure measurement: what is the international consensus? Hypertension 2013 0.99
67 Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens 2002 0.99
68 Home blood pressure monitoring in clinical practice: how many measurements and when? J Hypertens 2007 0.97
69 Day-night blood pressure variations: mechanisms, reproducibility and clinical relevance. J Hypertens 2007 0.97
70 Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens 2006 0.97
71 Impact of home patient telemonitoring on use of β-blockers in congestive heart failure. Drugs Aging 2010 0.96
72 How to best assess blood pressure? The ongoing debate on the clinical value of blood pressure average and variability. Hypertension 2011 0.96
73 Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials. J Hypertens 2016 0.95
74 Wearable seismocardiography. Conf Proc IEEE Eng Med Biol Soc 2007 0.94
75 Mechanisms of blood pressure and heart rate variability: an insight from low-level paraplegia. Am J Physiol Regul Integr Comp Physiol 2006 0.94
76 The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens 2006 0.93
77 Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens 2012 0.93
78 Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. Nephrol Dial Transplant 2013 0.93
79 Daily life blood pressure changes are steeper in hypertensive than in normotensive subjects. Hypertension 2003 0.93
80 Sleep apnoea and the heart. Eur Respir Rev 2013 0.92
81 Self measured and ambulatory blood pressure in assessing the 'white-coat' phenomenon. J Hypertens 2003 0.92
82 White coat effect: semantics, assessment and pathophysiological implications. J Hypertens 2003 0.92
83 Continuous positive airway pressure increases haemoglobin O2 saturation after acute but not prolonged altitude exposure. Eur Heart J 2009 0.91
84 Thirty years of research on diagnostic and therapeutic thresholds for the self-measured blood pressure at home. Blood Press Monit 2008 0.91
85 Seasonal variations in blood pressure: a complex phenomenon. J Hypertens 2012 0.91
86 Assessment of the autonomic control of heart rate variability in healthy and spinal-cord injured subjects: contribution of different complexity-based estimators. IEEE Trans Biomed Eng 2006 0.90
87 Determinants of heart rate and heart rate variability. J Hypertens 2003 0.90
88 Muscle metaboreflex contribution to cardiovascular regulation during dynamic exercise in microgravity: insights from mission STS-107 of the space shuttle Columbia. J Physiol 2006 0.90
89 Arterial stiffness and 24 h ambulatory blood pressure monitoring in young healthy volunteers: the early vascular ageing Aristotle University Thessaloniki Study (EVA-ARIS Study). Atherosclerosis 2011 0.90
90 Persistently elevated heart rate accelerates the progression of arterial stiffness. J Hypertens 2010 0.90
91 Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials. J Hypertens 2014 0.90
92 Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure. Clin Endocrinol (Oxf) 2012 0.89
93 Blood pressure variability: an additional target for antihypertensive treatment? Hypertension 2011 0.89
94 Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens 2014 0.89
95 Transthoracic impedance accurately estimates pulmonary wedge pressure in patients with decompensated chronic heart failure. Congest Heart Fail 2011 0.89
96 Short-term and long-term repeatability of the morning blood pressure in older patients with isolated systolic hypertension. J Hypertens 2008 0.88
97 Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses. J Hypertens 2015 0.88
98 Device-guided slow breathing as a non-pharmacological approach to antihypertensive treatment: efficacy, problems and perspectives. J Hypertens 2007 0.87
99 Validation of the Artsana CSI 610 automated blood pressure monitor in adults according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007 0.87
100 Local scale exponents of blood pressure and heart rate variability by detrended fluctuation analysis: effects of posture, exercise, and aging. IEEE Trans Biomed Eng 2009 0.87
101 Disappearance of isocapnic buffering period during increasing work rate exercise at high altitude. Eur J Cardiovasc Prev Rehabil 2008 0.87
102 Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Cardiovasc Genet 2017 0.87
103 Environmental and genetic contribution to hypertension prevalence: data from an epidemiological survey on Sardinian genetic isolates. PLoS One 2013 0.86
104 Enhanced reflex response to baroreceptor deactivation in subjects with tilt-induced syncope. J Am Coll Cardiol 2003 0.86
105 Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) 2011 0.86
106 High-altitude hypoxia and periodic breathing during sleep: gender-related differences. J Sleep Res 2013 0.86
107 Requirements for professional office blood pressure monitors. J Hypertens 2012 0.86
108 Calcium antagonist added to angiotensin receptor blocker: a recipe for reducing blood pressure variability?: evidence from day-by-day home blood pressure monitoring. Hypertension 2012 0.85
109 The interleukin-6 -174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. Int J Cardiol 2005 0.85
110 Blood pressure variability, target organ damage and cardiovascular events. J Hypertens 2002 0.85
111 Zofenopril plus hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension. Drugs 2006 0.85
112 Home blood pressure control is low during the critical morning hours in patients with hypertension: the SURGE observational study. Fam Pract 2011 0.85
113 Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens 2014 0.85
114 Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk--overview and meta-analyses of randomized trials. J Hypertens 2014 0.85
115 Increased short-term blood pressure variability is associated with early left ventricular systolic dysfunction in newly diagnosed untreated hypertensive patients. J Hypertens 2013 0.84
116 Evaluating aortic stiffness through an arm cuff oscillometric device: is validation against invasive measurements enough? J Hypertens 2010 0.84
117 Prognostic relevance of blood pressure variability. Hypertension 2005 0.84
118 Improvement in left ventricular diastolic stiffness induced by physical training in patients with dilated cardiomyopathy. J Card Fail 2008 0.84
119 Autonomic cardiac modulation in obstructive sleep apnea: effect of an oral jaw-positioning appliance. Chest 2006 0.84
120 Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease. Mov Disord 2010 0.84
121 [Disease management for heart failure patients: role of wireless technologies for telemedicine. The ICAROS project]. G Ital Cardiol (Rome) 2007 0.84
122 Orthostatic hypertension: home blood pressure monitoring for detection and assessment of treatment with doxazosin. Hypertens Res 2011 0.84
123 Variable day/night bias in 24-h non-invasive finger pressure against intrabrachial artery pressure is removed by waveform filtering and level correction. J Hypertens 2002 0.84
124 Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses. J Hypertens 2015 0.84
125 Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention 2013 0.83
126 High-altitude exposure of three weeks duration increases lung diffusing capacity in humans. J Appl Physiol (1985) 2011 0.83
127 Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens 2016 0.83
128 Blood pressure measurement in very obese patients: a challenging problem. J Hypertens 2011 0.83
129 Obtaining arterial stiffness indices from simple arm cuff measurements: the holy grail? J Hypertens 2009 0.83
130 Assessing the white-coat effect: which blood pressure measurement should be considered? J Hypertens 2006 0.83
131 Standards for ambulatory blood pressure monitoring clinical reporting in daily practice: recommendations from the Italian Society of Hypertension. Blood Press Monit 2015 0.82
132 Non-invasive diagnostic testing for coronary artery disease in the hypertensive patient: potential advantages of a risk estimation-based algorithm. Am J Hypertens 2012 0.82
133 Determinants of blood pressure variability in youth: at the roots of hypertension. J Hypertens 2010 0.82
134 Index measured at an intermediate altitude to predict impending acute mountain sickness. Med Sci Sports Exerc 2011 0.82
135 Obstructive sleep apnea syndrome: a cause of acute delirium. J Clin Sleep Med 2009 0.82
136 Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival. J Cardiovasc Pharmacol 2012 0.82
137 Transthoracic bioimpedance and brain natriuretic peptide levels accurately indicate additional diastolic dysfunction in patients with chronic advanced systolic heart failure. Eur J Heart Fail 2010 0.81
138 The influence of illness severity on health satisfaction in patients with cardiovascular disease: the mediating role of illness perception and self-efficacy beliefs. Behav Med 2014 0.81
139 Textile technology for the vital signs monitoring in telemedicine and extreme environments. IEEE Trans Inf Technol Biomed 2010 0.81
140 Lung ultrasound and transthoracic impedance for noninvasive evaluation of pulmonary congestion in heart failure. J Cardiovasc Med (Hagerstown) 2016 0.81
141 Heart rate variability and nonlinear dynamic analysis in patients with stress-induced cardiomyopathy. Med Biol Eng Comput 2012 0.81
142 Effects of acute and long-term slow breathing exercise on muscle sympathetic nerve activity in untreated male patients with hypertension. J Hypertens 2013 0.81
143 Guiding antihypertensive treatment decisions using ambulatory blood pressure monitoring. Curr Hypertens Rep 2006 0.81
144 Use of automated blood pressure measurements in clinical trials and registration studies: data from the VALTOP Study. Blood Press Monit 2010 0.81
145 Assessing the fractal structure of heart rate by the temporal spectrum of scale exponents: a new approach for detrended fluctuation analysis of heart rate variability. Biomed Tech (Berl) 2011 0.81
146 Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials. J Hypertens 2016 0.81
147 Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude. J Hypertens 2011 0.81
148 Acute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project. Respir Physiol Neurobiol 2013 0.80
149 The optimal schedule for self-monitoring of blood pressure by patients at home. J Hypertens 2007 0.80
150 Wake-up stroke and TIA due to paradoxical embolism during long obstructive sleep apnoeas: a cross-sectional study. Thorax 2012 0.80
151 Office and 24-h ambulatory blood pressure control by treatment in general practice: the 'Monitoraggio della pressione ARteriosa nella medicina TErritoriale' study. J Hypertens 2010 0.80
152 Accuracy of blood pressure measurement: sphygmomanometer calibration and beyond. J Hypertens 2006 0.80
153 Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol 2012 0.80
154 Role of birth weight and postnatal growth on pulse wave velocity in teenagers. J Adolesc Health 2012 0.80
155 Twenty-four-hour ambulatory blood pressure profiles of high-risk patients in general practice: data from an ambulatory blood pressure monitoring registry. J Hypertens 2007 0.80
156 A new index of sodium sensitivity risk from arterial blood pressure monitoring during habitual salt intake. Int J Cardiol 2013 0.80
157 Assessing the sensitivity of spontaneous baroreflex control of the heart: deeper insight into complex physiology. Hypertension 2004 0.80
158 Cardiovascular Management Self-efficacy: Psychometric Properties of a New Scale and Its Usefulness in a Rehabilitation Context. Ann Behav Med 2015 0.79
159 Psychological predictors of the antihypertensive effects of music-guided slow breathing. J Hypertens 2010 0.79
160 Evaluation of a textile-based wearable system for the electrocardiogram monitoring in cardiac patients. Europace 2012 0.79
161 Left ventricular ejection time, not heart rate, is an independent correlate of aortic pulse wave velocity. J Appl Physiol (1985) 2013 0.79
162 Rate of blood pressure changes assessed by 24 h ambulatory blood pressure monitoring: another meaningful index of blood pressure variability? J Hypertens 2011 0.79
163 Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure - meta-analyses of randomized trials. J Hypertens 2016 0.79
164 Arterial baroreflex modulation of sympathetic activity and arterial wall properties: new evidence. Hypertension 2011 0.79
165 Multiple multilayer stents for thoracoabdominal aortic aneurysm: a possible new tool for aortic endovascular surgery. Int J Gen Med 2012 0.79
166 A wearable system for the seismocardiogram assessment in daily life conditions. Conf Proc IEEE Eng Med Biol Soc 2011 0.79
167 Effects of slow deep breathing at high altitude on oxygen saturation, pulmonary and systemic hemodynamics. PLoS One 2012 0.79
168 Prognostic value of noninvasive hemodynamic evaluation of the acute effect of levosimendan in advanced heart failure. J Cardiovasc Med (Hagerstown) 2014 0.78
169 Aortic stiffness and myocardial ischemia. J Hypertens 2015 0.78
170 How should the baroreflex sensitivity on the heart be estimated? J Electrocardiol 2011 0.78
171 Response to: nocturnal blood pressure dipping: systolic, diastolic or both? J Hypertens 2014 0.78
172 Analysis and interpretation of 24-h blood pressure profiles: appropriate mathematical models may yield deeper understanding. Am J Hypertens 2008 0.78
173 Modulation of urinary peptidome in humans exposed to high altitude hypoxia. Mol Biosyst 2011 0.78
174 The use of echocardiography in observational clinical trials: the EURECA-m registry. Nephrol Dial Transplant 2012 0.78
175 Reflecting on posture. J Hypertens 2011 0.78
176 Validation of the Artsana CS 410 automated blood pressure monitor in adults according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2008 0.78
177 Temporal blood pressure patterns and cardiovascular events: 'good night' or 'good morning'? J Hypertens 2006 0.78
178 Home blood pressure monitoring may make office measurements obsolete. J Hypertens 2012 0.78
179 Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit 2015 0.78
180 Zofenopril plus hydrochlorothiazide fixed combination in the treatment of hypertension and associated clinical conditions. Cardiovasc Ther 2009 0.78
181 Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database. J Hypertens 2016 0.78
182 How to best monitor blood pressure at home? Assessing numbers and individual patients. J Hypertens 2010 0.78
183 Cardiac sounds from a wearable device for sternal seismocardiography. Conf Proc IEEE Eng Med Biol Soc 2011 0.78
184 Self blood pressure measurement at home: how many times? J Hypertens 2004 0.78
185 Home blood pressure monitoring: a tool for better hypertension control. Hypertension 2010 0.78
186 Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure. J Cardiovasc Med (Hagerstown) 2010 0.78
187 Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study. J Hypertens 2015 0.77
188 Time-weighted vs. conventional quantification of 24-h average systolic and diastolic ambulatory blood pressures. J Hypertens 2010 0.77
189 Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). J Hypertens 2002 0.77
190 Effects of continuous positive airway pressure therapy on hypertension control in patients with sleep-related breathing disorders: available evidence and unresolved issues. J Hypertens 2010 0.77
191 Vascular Health Assessment of The Hypertensive Patients (VASOTENS) Registry: Study Protocol of an International, Web-Based Telemonitoring Registry for Ambulatory Blood Pressure and Arterial Stiffness. JMIR Res Protoc 2016 0.77
192 Diastolic dysfunction and abnormal exercise ventilation predict adverse outcome in elderly patients with chronic systolic heart failure. Eur J Prev Cardiol 2011 0.77
193 Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions - Position statement of the European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability. J Hypertens 2016 0.77
194 Mechanical and neural components of the cardiac baroreflex: new insights into complex physiology. J Hypertens 2005 0.77
195 Sex and age differences in the relationship between sleep duration and hypertension. J Hypertens 2010 0.77
196 Assessing circadian blood pressure and heart rate changes: advantages and limitations of different methods of mathematical modelling. J Hypertens 2004 0.77
197 Transthoracic bioimpedance and brain natriuretic peptide assessment for prognostic stratification of outpatients with chronic systolic heart failure. Clin Cardiol 2013 0.77
198 Evening administration of antihypertensive drugs: filling a knowledge gap. J Hypertens 2010 0.77
199 Local-scale analysis of cardiovascular signals by detrended fluctuations analysis: effects of posture and exercise. Conf Proc IEEE Eng Med Biol Soc 2007 0.77
200 Design of the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study to assess the ability of remote monitoring to treat and triage patients more effectively. Trials 2009 0.77
201 Blood pressure variability, target organ damage and antihypertensive treatment. J Hypertens 2003 0.77
202 How to assess arterial compliance in humans. J Hypertens 2006 0.77
203 Office and out of office heart rate measurements: which clinical value? J Hypertens 2008 0.77
204 Correlation between trans and intra-thoracic impedance and conductance in patients with chronic heart failure. J Cardiovasc Med (Hagerstown) 2016 0.76
205 Very low frequency blood pressure fluctuations: not only myogenic responsiveness. J Hypertens 2008 0.76
206 Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects. Cardiovasc Ther 2011 0.76
207 Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects. J Am Coll Cardiol 2015 0.76
208 Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2005 0.76
209 Cardiac index assessment: validation of a new non-invasive very low current thoracic bioimpedance device by thermodilution. Blood Press 2013 0.76
210 Is essential hypertension sometimes a psychosomatic disorder? J Hypertens 2004 0.76
211 Clinical relevance of day-by-day blood pressure and heart rate variability: new information from home self-measurements. Hypertension 2008 0.76
212 How to improve the assessment of 24-h blood pressure variability. Blood Press Monit 2005 0.76
213 Home blood pressure monitoring in general practice: expectations and concerns. J Hypertens 2006 0.76
214 Present trends and future directions in the analysis of cardiovascular variability. J Hypertens 2011 0.75
215 Reverting to simplicity: palpating SBP. J Hypertens 2011 0.75
216 Blood pressure up in a puff of smoke. J Hypertens 2010 0.75
217 Sleep patterns and high blood pressure: more evidence needed. J Hypertens 2012 0.75
218 Is intensified diuretic therapy an effective new treatment strategy in obstructive sleep apnoea patients with uncontrolled hypertension? J Hypertens 2014 0.75
219 Should the measurement of blood pressure in the office be redefined? J Hypertens 2012 0.75
220 Cotinine and blood pressure levels: variability omitted once again. Hypertension 2013 0.75
221 Heritability of arterial stiffness and central blood pressure: the Holy Grail for detecting patients at high cardiovascular risk? J Hypertens 2012 0.75
222 Retrograde approach using the right axillary artery for complete endovascular treatment of a symptomatic aberrant right subclavian artery aneurysm. J Endovasc Ther 2012 0.75
223 Seasonal blood pressure changes: which ambient temperature should we consider? J Hypertens 2014 0.75
224 Trough-to-peak ratio, smoothness index and morning-to-evening ratio: why, which and when? J Hypertens 2003 0.75
225 Out-of-office blood pressure measurement in children and adolescents. J Hypertens 2008 0.75
226 Weight and blood pressure changes in high vascular risk patients. J Clin Hypertens (Greenwich) 2013 0.75
227 Home or ambulatory blood pressure monitoring for the diagnosis of hypertension? J Hypertens 2015 0.75
228 Natriuretic peptides and cardiovascular variability. J Hypertens 2015 0.75
229 Combined exercise training in postmenopausal women: implications for vascular hemodynamics. J Clin Hypertens (Greenwich) 2013 0.75
230 Acute stress and long-lasting blood pressure elevation: a possible cause of established hypertension? J Hypertens 2005 0.75
231 Improvements on cuff measurement of arterial pressure: more cuffs! J Hypertens 2013 0.75
232 Arterial applanation tonometry: technical aspects relevant for its daily clinical use. J Hypertens 2013 0.75
233 Is daytime siesta a harmful habit? J Hypertens 2014 0.75
234 What are the real determinants of the ambulatory arterial stiffness index? J Hypertens 2012 0.75
235 Electrical carotid baroreceptor stimulation in resistant hypertension. Hypertension 2010 0.75
236 Cardiac oxygen supply is compromised during the night in hypertensive patients. Med Biol Eng Comput 2011 0.75
237 Ambulatory blood pressure monitoring in clinical practice. J Hypertens 2002 0.75
238 Need for better blood pressure measurement in developing countries to improve prevention of cardiovascular disease. J Epidemiol 2014 0.75
239 Response to seasonal changes in blood pressure: possible interaction between sunlight and brain serotonin. Hypertension 2013 0.75
240 Augmentation index as a specific marker of large arteries distensibility: the end of a beautiful tale? J Hypertens 2012 0.75
241 Determinants of the ambulatory arterial stiffness index regression line. Hypertension 2009 0.75
242 Hypertension drug trials based on ambulatory blood pressure monitoring: when is a double-blind controlled design needed? J Hypertens 2003 0.75
243 Further insights into the 24-h blood pressure profile by home blood pressure monitoring: the issue of morning hypertension. J Hypertens 2009 0.75
244 Glucose tolerance and weight loss in obese women with obstructive sleep apnea. PLoS One 2013 0.75
245 A cautious view of the relationship between ambulatory blood pressure monitoring data and salt-sensitivity of blood pressure. Reply. J Hypertens 2013 0.75
246 Assessing sodium sensitivity in clinical practice: new insights from ambulatory blood pressure monitoring data. J Hypertens 2013 0.75
247 Cardiovascular variability analysis. An insight into the pathophysiology of cardiovascular disease and the impact of treatment. With caution. Clin Auton Res 2002 0.75
248 Masked hypertension: an independent predictor of organ damage. J Hypertens 2007 0.75
249 Methodological aspects in the measurement of pulse wave velocity by means of applanation tonometry. J Hypertens 2013 0.75
250 Isolated clinic hypertension in a general population. J Hypertens 2006 0.75
251 Modulation of 24-h blood pressure profiles: a new target for treatment? J Hypertens 2005 0.75
252 Renal sympathetic denervation and daily life blood pressure in resistant hypertension: simplicity or complexity? Circulation 2013 0.75
253 Effects of hypoxia on blood pressure regulation: interval hypoxic training as compared to obstructive sleep apnea - the other side of the coin? J Hypertens 2009 0.75
254 Where is the fractal component of heart rate spectra hiding? Anesth Analg 2010 0.75
255 Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude. Chest 2015 0.75
256 Control of hypertension in nonsleepy patients with obstructive sleep apnea. Am J Respir Crit Care Med 2010 0.75
257 Autonomic arousals in sleep related breathing disorders: a link between daytime somnolence and hypertension? Sleep 2009 0.75
258 Hypertension staging through ambulatory blood pressure monitoring. Hypertension 2002 0.75
259 Self-measurement of blood pressure in the office and at home. J Hypertens 2003 0.75
260 Assessing the genetic background of arterial baroreflex sensitivity: a complex issue. J Hypertens 2005 0.75
261 Obesity, hypertension and the sympathetic nervous system. J Hypertens 2002 0.75
262 Twenty-four-hour ambulatory central blood pressure: new perspectives for blood pressure measurement? J Hypertens 2014 0.75
263 A patient-centric Web-based approach to improve hypertension management: a lesson learned from postmenopausal women. J Clin Hypertens (Greenwich) 2013 0.75
264 An ICT and mobile health integrated approach to optimize patients' education on hypertension and its management by physicians: The Patients Optimal Strategy of Treatment(POST) pilot study. Conf Proc IEEE Eng Med Biol Soc 2016 0.75
265 Distinct Patterns of Hyperpnea During Cheyne-Stokes Respiration: Implication for Cardiac Function in Patients With Heart Failure. J Clin Sleep Med 2017 0.75
266 The Istituto Auxologico Italiano: an institute in Italy dedicated to biomedical research and health care. Eur Heart J 2015 0.75
267 Influence of sympathetic vascular regulation on heart-rate scaling structure: spinal cord lesion as a model of progressively impaired autonomic control. Biomed Tech (Berl) 2006 0.75
268 Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients. J Hypertens 2017 0.75
269 Reply. J Hypertens 2017 0.75
270 Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide. Hypertension 2013 0.75
271 Plasma fatty acids response to central volume expansion in salt-sensitive hypertension. Metabolism 2003 0.75
272 Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). J Hypertens 2017 0.75
273 Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction. Circ J 2015 0.75
274 Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure: overview and meta-analyses of randomized trials. J Hypertens 2017 0.75
275 MagIC system. Advancements in the monitoring of cardiorespiratory function in active people byt extile technology. IEEE Eng Med Biol Mag 2009 0.75
276 A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure. J Hypertens 2016 0.75
277 Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials. J Hypertens 2016 0.75
278 Wearable seismocardiography for the beat-to-beat assessment of cardiac intervals during sleep. Conf Proc IEEE Eng Med Biol Soc 2014 0.75
279 Prognostic value of indeterminable anaerobic threshold in heart failure. Circ Heart Fail 2013 0.75
280 Central diastolic pressure exponential decay constant and subendocardial flow supply. J Hypertens 2017 0.75
281 The effects of telmisartan alone or in combination with hydrochlorothiazide on morning home blood pressure control: the SURGE 2 practice-based study. Blood Press 2013 0.75
282 Changes in 24-hour ambulatory blood pressure monitoring during the 2009 earthquake at L'Aquila. Am J Med 2010 0.75
283 Expertise: no longer a sine qua non for guideline authors? J Hypertens 2017 0.75
284 Mediterranean diet impact on cardiovascular diseases: a narrative review. J Cardiovasc Med (Hagerstown) 2017 0.75
285 Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration? J Cardiovasc Med (Hagerstown) 2020 0.75
286 Potassium supplementation improves the natriuretic response to central volume expansion in primary aldosteronism. Metabolism 2003 0.75
287 Insulin resistance and beat-to-beat cardiovascular dynamics: a constant relationship across different body mass index and blood pressure categories. J Clin Endocrinol Metab 2014 0.75
288 Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring. Drugs Aging 2002 0.75
289 Validation of noninvasive devices for central blood pressure assessment: a yet unresolved issue. J Hypertens 2016 0.75
290 Ambulatory blood pressure monitoring: a mandatory approach in high-risk pregnancy? J Hypertens 2016 0.75
291 Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment. J Hypertens 2017 0.75
292 Aldosterone-to-renin ratio depends on age and sex in children attending a clinic for cardiovascular risk assessment. J Hypertens 2017 0.75
293 Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials. J Hypertens 2017 0.75
294 HEARTFAID: A knowledge based platform of services for supporting medical-clinical management of heart failure within elderly population. Stud Health Technol Inform 2006 0.75
295 [What underlies NYHA class in elderly patients with heart failure? Role of diastolic dysfunction, functional mitral regurgitation and abnormal ventilation during exercise]. Monaldi Arch Chest Dis 2009 0.75
296 Does ABPM replace office blood pressure measurement in the clinical evaluation of patients? Point of view--not yet. Rev Assoc Med Bras 2007 0.75
297 Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. J Hypertens 2016 0.75
298 Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials. J Hypertens 2017 0.75
299 A randomized and controlled study of noninvasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients. J Hypertens 2015 0.75
300 The PON1192RR genotype is associated with a higher prevalence of arterial hypertension. J Hypertens 2006 0.75
301 Influence of carotid atherosclerotic plaques on pulse wave assessment with arterial tonometry. J Hypertens 2017 0.75
302 Awareness of hypertension consequences is less than awareness of risk factors for hypertension. J Cardiovasc Med (Hagerstown) 2017 0.75
303 Breath holding as a specific type of breathing training from the viewpoint of Avicenna. Authors' reply. Pol Arch Intern Med 2017 0.75
304 HIGHCARE: the HIGH altitude CArdiovascular Research study: a scientific expedition on Mount Everest to measure the effects of altitude on blood pressure. Eur Heart J 2015 0.75
305 Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens 2016 0.75
306 Acute Increase of Cardiac Output Reduces Central Sleep Apneas in Heart Failure Patients. J Am Coll Cardiol 2015 0.75
307 Renal and cardiovascular responses to water immersion in essential hypertension: is there a role for the opioidergic system? Nephron Physiol 2003 0.75
308 Seismocardiography while sleeping at high altitude. Conf Proc IEEE Eng Med Biol Soc 2012 0.75
309 Obstructive Sleep Apnea Syndrome (OSAS) and Cardiovascular System. Med Lav 2017 0.75
310 Influence of autonomic impairment on blood-pressure and heart-rate scaling structures. Conf Proc IEEE Eng Med Biol Soc 2006 0.75
311 PA.NET International Quality Certification Protocol for blood pressure monitors. Blood Press Monit 2008 0.75
312 [The strange story of the Sherpa and the tank of carbon monoxide: that is the story of a scientific adventure. A HIGHCARE 2008 substudy]. G Ital Cardiol (Rome) 2009 0.75
313 Management of heart failure in the new era: the role of scores. J Cardiovasc Med (Hagerstown) 2016 0.75
314 Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension. J Hypertens 2015 0.75
315 Left atrial enlargement and right ventricular hypertrophy in essential hypertension. Blood Press 2013 0.75